Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzhenghuayu + Huangqi Decoction is a combination of two traditional Chinese medicine (TCM) formulas used primarily for the treatment of liver fibrosis and cirrhosis. Fuzheng Huayu (FZHY) is a SFDA-approved antifibrotic herbal formula in China, composed of six herbs including Radix Salvia Miltiorrhizae, Cordyceps, Semen Persicae, Gynostemma Pentaphyllum, Pollen Pini, and Fructus Schisandrae Chinensis[1][2][5]. It acts by promoting blood flow, dissolving blood stasis, nourishing the liver, inhibiting hepatic stellate cell activation, protecting hepatocytes from injury and apoptosis, regulating macrophage polarization/chemotaxis (notably via CCL2 and CX3CL1), and reducing extracellular matrix deposition[2][3]. Huangqi Decoction refers to an Astragalus-based herbal mixture commonly used in TCM for its immunomodulatory and hepatoprotective effects. The combination aims to synergistically enhance antifibrotic efficacy through multi-target actions such as anti-inflammation, antioxidation, immune regulation and improvement of microcirculation. Clinical studies suggest this combination can improve liver function tests and quality of life in patients with chronic hepatitis B-related fibrosis or cirrhosis[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fuzhenghuayu + huangqi decoction.